Boston-based Dana-Farber Cancer Institute has received $27.8 million in support of multiple myeloma research.
The gift will establish the Giuliani Family Fund for Myeloma Clinical Research and the Giuliani Family Fund for Myeloma Therapeutic Discovery, according to a Sept. 2 news release from Dana-Farber.
The Myeloma Clinical Research fund will support a clinical trial led by Paul Richardson, MD, clinical program leader and director of clinical research at Dana-Farber’s Jerome Lipper Multiple Myeloma Center and the R.J. Corman Professor of Medicine at Boston-based Harvard Medical School. The trial aims to evaluate how to incorporate immunotherapies into multiple myeloma treatment protocols.
The Myeloma Therapeutic Discovery fund will support research led by Constantine Mitsiades, MD, PhD, associate professor of medicine at Dana-Farber and Harvard Medical School.
The gift was made by Mario Germano Giuliani and Lisa Giuliani, according to the news release.
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
